🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase IIa, randomized, multi-site, two-arm, double-blinded ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-27
Trial ID
NCT02076178
Treatments Being Tested
This will be a two-part study in healthy adults. Part A is a phase 1, non-r...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05
Trial ID
NCT01848340
Treatments Being Tested
This is an active control, randomized study to investigate the safety, tole...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-07-31
Trial ID
NCT04484337
This study will evaluate the safety and efficacy of the injectable drug cab...
Status
Completed
Location
Alabama CRS
Start Date
2016-12-19
Trial ID
NCT02720094
The CAPRISA 014 trial aims to assess the safety and acceptability of the lo...
Status
Withdrawn
Location
CAPRISA eThekwini Research Clinic
Start Date
2015-10
Trial ID
NCT02462772
Treatments Being Tested
The study is designed to select a dose of GSK1265744 primarily on the basis...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-06
Trial ID
NCT01641809
This study will evaluate the safety and efficacy of the long-acting injecta...
Status
Active Not Recruiting
Location
Gaborone CRS
Start Date
2017-11-07
Trial ID
NCT03164564
Treatments Being Tested
This study is being conducted to comply with the Food and Drug Administrati...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-01
Trial ID
NCT02027454
Treatments Being Tested
This study will evaluate the safety, tolerability, and pharmacokinetics (wh...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2015-02
Trial ID
NCT02178800